Liquid Biopsy in Gastrointestinal Cancers: How Close Are We to Reaching the Clinic?

Julie Earl; Agapi Kataki; Bozena Smolkova

doi:10.3390/cancers15102831

Liquid Biopsy in Gastrointestinal Cancers: How Close Are We to Reaching the Clinic?

Cancers (Basel). 2023 May 19;15(10):2831. doi: 10.3390/cancers15102831.

Authors

Julie Earl¹, Agapi Kataki², Bozena Smolkova³

Affiliations

¹ Molecular Epidemiology and Predictive Tumor Markers Group, Ramón y Cajal Health Research Institute (IRYCIS), Carretera Colmenar Km 9100, CIBERONC, 28034 Madrid, Spain.
² 1st Department of Propaedeutic Surgery, National and Kapodistrian University of Athens, Vasilissis Sofias 114, 11527 Athens, Greece.
³ Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska Cesta 9, 845-05 Bratislava, Slovakia.

Abstract

Gastrointestinal (GI) cancers are malignancies that develop within the digestive system and account for one in four cancer cases according to WHO data [...].

Publication types

Editorial

Grants and funding

This research was funded by the European Union’s Horizon 2020 research and innovation program under grant agreement No 857381/VISION, the Spanish Biomedical Research Network in Cancer CIBERONC (CB16/12/00446), from the Slovak Research and Development Agency (APVV-21-0197, APVV-20-0143) and TRANSCAN-2 program ERA-NET JTC 2017 “Translational research on rare cancers” within the project NExT.